首页> 外文OA文献 >A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

【2h】

A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

机译：一期研究，评估基于抗体的组织因子拮抗剂在急性肺损伤或急性呼吸窘迫综合征患者中的药代动力学，安全性和耐受性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Peter E Morris; Jay S Steingrub; Bee Y Huang; Shamay Tang; Patrick M Liu; Peter R Rhode; Hing C Wong;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome [J] . Peter E Morris, Jay S Steingrub, Bee Y Huang, BMC Pulmonary Medicine . 2012,第1期

机译：一期研究，评估基于抗体的组织因子拮抗剂在急性肺损伤或急性呼吸窘迫综合征患者中的药代动力学，安全性和耐受性
2. A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome. [J] . Vincent JL, Artigas A, Petersen LC, Critical care medicine . 2009,第6期

机译：一项多中心，随机，双盲，安慰剂对照，剂量递增试验，评估了活性位点灭活的重组因子VIIa在患有急性肺损伤或急性呼吸窘迫综合征的受试者中的安全性和有效性。
3. Retrospective evaluation of the prevalence, risk factors, management, outcome, and necropsy findings of acute lung injury and acute respiratory distress syndrome in dogs and cats: 29 cases (2011鈥?013) [J] . Journal of Veterinary Emergency and Critical Care . 2017,第6期

机译：回顾性评价犬和猫类急性肺损伤和急性呼吸窘迫综合征的患病率，危险因素，管理，结果和尸检结果：29例（2011年鈥？013）
4. Incidence and Clinical Features of Acute Lung Injury/ Adult Respiratory Distress Syndrome Complicating Acute Myocardial Infarction Patients Treated with Primary Angioplasty [C] . Garcia Gonzalez M.J., Juarez Prera R., Blanco Palacios G., International Congress on Coronary Artery Disease . 2009

机译：急性肺损伤/成人呼吸窘迫综合征复杂性急性心肌梗死患者的发病率和临床特征对初级血管成形术治疗的急性心肌梗死患者
5. Use of Tat-HSP70 fusion protein to attenuate sepsis-induced lung injury in rodents with acute respiratory distress syndrome caused by cecal ligation and double puncture (2CLP) [D] . Lyons, Mary Melanie 2013

机译：使用TAT-HSP70融合蛋白在术中患有急性呼吸窘迫综合征的啮齿动物患者患者患者患者引起的盲肠结扎和双刺穿（2CLP）
6. A phase I study evaluating the pharmacokinetics safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome [O] . Peter E Morris, Jay S Steingrub, Bee Y Huang, 2012

机译：I期研究评估基于抗体的组织因子拮抗剂在急性肺损伤或急性呼吸窘迫综合征患者中的药代动力学安全性和耐受性
7. A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome [O] . Morris, Peter E, Steingrub, Jay S, Huang, Bee Y, 2012

机译：一期研究，评估基于抗体的组织因子拮抗剂在急性肺损伤或急性呼吸窘迫综合征患者中的药代动力学，安全性和耐受性

A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

著录项

引文网络

相似文献

相关主题

期刊订阅